Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03762317 · ClinicalTrials.gov registry record · Phase 4
Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome
A Phase 4 study, sponsored by Hennepin County Medical Center, Minneapolis.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03762317 is a Phase 4 study that was terminated before completion, run by Hennepin County Medical Center, Minneapolis. The registered enrollment target is 10 participants.
The verdict
NCT03762317, a Phase 4 study, was terminated before completion, sponsored by Hennepin County Medical Center, Minneapolis.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a prospective randomized double blinded study comparing the effect on duration of pharmacologic treatment and duration of hospital stay when using clonidine at 12 µg/kilogram/day as an adjunct to oral morphine as compared to morphine monotherapy in the management of term and near term infants with neonatal abstinence syndrome (NAS)
Interventions
- DRUG Placebo
- DRUG Clonidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2018-12-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03762317
The ClinicalTrials.gov registry entry for NCT03762317 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin County Medical Center, Minneapolis, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03762317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03762317 about?
NCT03762317 is a clinical study titled "Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome". This is a prospective randomized double blinded study comparing the effect on duration of pharmacologic treatment and duration of hospital stay when using clonidine at 12 µg/kilogram/day as an adjunct to oral morphine as compared to morphine monotherapy in the management of term and near term infant...
What is the current status of trial NCT03762317?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2018-04-30. Estimated completion is 2018-12-12.
What interventions are being tested in trial NCT03762317?
The interventions under investigation include: Placebo (DRUG), Clonidine (DRUG).
Who is sponsoring clinical trial NCT03762317?
This trial is sponsored by Hennepin County Medical Center, Minneapolis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.